HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative activity of erythrocyte adenosine deaminase and orotidine decarboxylase in Diamond-Blackfan anemia.

Abstract
It previously has been reported that red blood cells (RBC) of patients with Diamond-Blackfan syndrome (DBS) have increased activity of orotidine decarboxylase (ODC) and adenosine deaminase (ADA). The studies reported here compared the activity of these two enzymes in DBS erythrocytes, cord blood, and reticulocytes. The activity of ODC, although increased in some DBS erythrocytes, was not significantly different from that seen in cord RBC or reticulocytes. In contrast, RBC-ADA activity was increased in 23 of 26 DBS patients; and this enzyme elevation was distinct from that seen in cord blood and reticulocytes. Moreover, ADA activity was normal in 26 of 27 patients with transient erythroblastopenia of childhood (TEC). Taken together, these data indicate RBC-ADA activity is more sensitive than ODC as a marker of DBS. In addition, RBC-ADA activity continues to be useful for distinguishing DBS and TEC in most patients with RBC hypoplasia.
AuthorsB E Glader, K Backer
JournalAmerican journal of hematology (Am J Hematol) Vol. 23 Issue 2 Pg. 135-9 (Oct 1986) ISSN: 0361-8609 [Print] United States
PMID3752068 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Nucleoside Deaminases
  • Adenosine Deaminase
  • Carboxy-Lyases
  • Orotidine-5'-Phosphate Decarboxylase
Topics
  • Adenosine Deaminase (blood)
  • Anemia, Aplastic (congenital, enzymology)
  • Carboxy-Lyases (blood)
  • Erythrocytes (enzymology)
  • Female
  • Fetal Blood (enzymology)
  • Humans
  • Nucleoside Deaminases (blood)
  • Orotidine-5'-Phosphate Decarboxylase (blood)
  • Pregnancy
  • Reference Values
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: